Corvus Pharmaceuticals, Inc.
CRVS
$14.06
-$0.02-0.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.21% | 57.71% | 57.49% | 99.80% | 91.40% |
| Total Receivables | 73.15% | 56.56% | 112.30% | 291.38% | 242.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -63.19% | -42.53% | -33.93% | 105.26% | 25.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -47.81% | 3.78% | 102.33% | 30.38% | 376.15% |
| Total Current Assets | 7.00% | 55.97% | 57.03% | 99.08% | 94.62% |
|
|
|||||
| Total Current Assets | 7.00% | 55.97% | 57.03% | 99.08% | 94.62% |
| Net Property, Plant & Equipment | -20.26% | 152.31% | 63.77% | 16.88% | -4.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.28% | 238.10% | 385.27% | 606.74% | 610.11% |
| Total Assets | 3.21% | 36.83% | 38.57% | 48.28% | 51.27% |
|
|
|||||
| Total Accounts Payable | -3.52% | 5.39% | 158.62% | -18.71% | 69.31% |
| Total Accrued Expenses | 81.84% | 35.20% | 14.56% | -8.14% | -7.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 117.84% | 7.06% | -49.29% | -69.33% | -86.54% |
| Total Finance Division Other Current Liabilities | -99.18% | -98.60% | -95.29% | 2,177.65% | 11,817.96% |
| Total Other Current Liabilities | -99.18% | -98.60% | -95.29% | 2,177.65% | 11,817.96% |
| Total Current Liabilities | -73.50% | -82.60% | -36.22% | 38.08% | 415.39% |
|
|
|||||
| Total Current Liabilities | -73.50% | -82.60% | -36.22% | 38.08% | 415.39% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -43.01% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -72.72% | -81.24% | -30.76% | 50.49% | 429.03% |
|
|
|||||
| Common Stock & APIC | 10.10% | 18.78% | 18.61% | 15.29% | 15.09% |
| Retained Earnings | -3.85% | -3.92% | -13.09% | -12.16% | -18.61% |
| Treasury Stock & Other | 30.43% | -43.63% | 15.28% | 1.65% | -33.20% |
| Total Common Equity | 87.93% | 478.35% | 56.62% | 47.84% | -15.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 87.93% | 478.35% | 56.62% | 47.84% | -15.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 87.93% | 478.35% | 56.62% | 47.84% | -15.81% |
|
|
|||||